Head of JLABS NYC - Boston - Philadelphia
As Head of Johnson & Johnson Innovation, JLABS in New York, Kate is responsible for external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming and P&L. She catalyzes and supports the translation of science and technology into valuable solutions for patients and consumers across the pharmaceutical, medical device, consumer and healthtech sectors.
Kate joins JLABS with 15 years of experience working across the Healthcare industry, starting in R&D before moving onto roles in Marketing, Business Development, External Alliances, Medical Affairs, Health Outcomes and most recently Disruptive Innovation. During her career Kate has been part of teams that have discovered new drugs, worked to develop and gain approval for blockbuster diabetes products and is passionate about being part of the future of healthcare where science intersects with the rapid advancements in health care technology.
Kate holds an undergraduate degree in Pharmacology & Toxicology from King’s College London, and a PhD in Pharmacology & Toxicology from University of California, Irvine Medical School. She received her MBA from the Fuqua School of Business at Duke University.